Label: CLARITIN- loratadine tablet, chewable

  • NDC Code(s): 11523-4330-1, 11523-4330-3, 11523-4330-4
  • Packager: Bayer HealthCare LLC.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated October 14, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active Ingredients

    Loratadine 5 mg

  • Purpose

    Antihistamine

  • INDICATIONS & USAGE

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
  • Do Not Use

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

  • AS a doctor before use if you have

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

  • When using this product

    When using this product do not take more than directed. Taking more than directed may cause drowsiness.

  • Stop use and ask a doctor if

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    adults and children 6 years and over

    chew 2 tablets daily; not more than 2 tablets in 24 hours

    children 2 to under 6 years of age

    		chew 1 tablet daily; not more than 1 tablet in 24 hours
    children under 2 years of age

    ask a doctor
    consumers with liver or kidney disease

    ask a doctor

  • Other information

    • phenylketonurics: contains phenylalanine 1.9 mg per tablet
    • safety sealed: do not use if the individual blister unit imprinted with Children’s Claritin® is open or torn
    • store between 20° to 25°C (68° to 77°F)
  • INACTIVE INGREDIENT

    aspartame, carmine, citric acid, colloidal silicon dioxide, flavor, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic acid

  • QUESTIONS

    1-800-CLARITIN

  • WARNINGS

  • PRINCIPAL DISPLAY PANEL

    ages

    2 years®

    and older

    Children's

    Claritin®

    Chewables

    loratadine 5 mg/antihistamine

    Indoor & Outdoor

    Allergies

    *When taken as directed.

    See Drug Facts Panel

    Non-Drowsy*

    24 Hour Relief of:

    • Sneezing
    • Runny Nose
    • Itchy, Watery Eyes
    • Itchy Throat or Nose

    Bubblegum

    Flavored

    10

    Chewable Tablets

    10-count carton

  • INGREDIENTS AND APPEARANCE
    CLARITIN 
    loratadine tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11523-4330
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE5 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MANNITOL (UNII: 3OWL53L36A)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ASPARTAME (UNII: Z0H242BBR1)  
    Product Characteristics
    Colorpink (Light to Medium Pink with a Slightly and/or Mottled Appearance) Scoreno score
    ShapeROUND (Round (Flat Faced Beveled Edge)) Size10mm
    FlavorBUBBLE GUMImprint Code C
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11523-4330-11 in 1 CARTON09/25/2015
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:11523-4330-33 in 1 CARTON09/25/2015
    210 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:11523-4330-44 in 1 CARTON09/25/2015
    310 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA02189109/25/2015
    Labeler - Bayer HealthCare LLC. (112117283)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!